Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
70880032 | 7088003 | 2 | F | 20070508 | 20160824 | 20090821 | 20160831 | EXP | US-PFIZER INC-2007036820 | PFIZER | 66.00 | YR | F | Y | 96.00000 | KG | 20160831 | MD | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
70880032 | 7088003 | 1 | PS | NAPROXEN. | NAPROXEN | 1 | Oral | UNK | Y | 0 | TABLET | ||||||||
70880032 | 7088003 | 2 | C | NEXIUM | ESOMEPRAZOLE MAGNESIUM | 1 | Oral | 20 MG, 1X/DAY | 0 | 20 | MG | TABLET | QD | ||||||
70880032 | 7088003 | 3 | C | ASPIRIN. | ASPIRIN | 1 | Oral | 325 MG, DAILY | 0 | 325 | MG | ||||||||
70880032 | 7088003 | 4 | C | PLAVIX | CLOPIDOGREL BISULFATE | 1 | Oral | 75 MG, DAILY | 0 | 75 | MG | ||||||||
70880032 | 7088003 | 5 | C | ATENOLOL. | ATENOLOL | 1 | Oral | 25 MG, DAILY | 0 | 25 | MG | ||||||||
70880032 | 7088003 | 6 | C | DIOVAN | VALSARTAN | 1 | Oral | 80 MG, DAILY | 0 | 80 | MG | ||||||||
70880032 | 7088003 | 7 | C | GLUCOPHAGE | METFORMIN HYDROCHLORIDE | 1 | Oral | 500 MG, 3X/DAY | 0 | 500 | MG | TID | |||||||
70880032 | 7088003 | 8 | C | GLIPIZIDE. | GLIPIZIDE | 1 | Oral | 5 MG, 2X/DAY | 0 | 5 | MG | BID | |||||||
70880032 | 7088003 | 9 | C | ZETIA | EZETIMIBE | 1 | Oral | 10 MG, DAILY | 0 | 10 | MG | ||||||||
70880032 | 7088003 | 10 | C | NIASPAN | NIACIN | 1 | Oral | 1500 MG, DAILY | 0 | 1500 | MG | ||||||||
70880032 | 7088003 | 11 | C | CALTRATE | CALCIUM CARBONATE | 1 | Oral | 1 TABLET, DAILY | 0 | 1 | DF | TABLET | |||||||
70880032 | 7088003 | 12 | C | NITROGLYCERIN. | NITROGLYCERIN | 1 | Oral | 0.4 MG, AS NEEDED | 0 | .4 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
70880032 | 7088003 | 1 | Osteoarthritis |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
70880032 | 7088003 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
70880032 | 7088003 | Coronary artery disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
70880032 | 7088003 | 1 | 20070405 | 20070508 | 0 | |
70880032 | 7088003 | 2 | 20070404 | 20070508 | 0 | |
70880032 | 7088003 | 3 | 20041228 | 0 | ||
70880032 | 7088003 | 4 | 20041228 | 0 | ||
70880032 | 7088003 | 5 | 20041228 | 0 | ||
70880032 | 7088003 | 6 | 1997 | 0 | ||
70880032 | 7088003 | 7 | 1999 | 0 | ||
70880032 | 7088003 | 8 | 1999 | 0 | ||
70880032 | 7088003 | 9 | 20050420 | 0 | ||
70880032 | 7088003 | 10 | 20050420 | 0 | ||
70880032 | 7088003 | 11 | 2004 | 0 | ||
70880032 | 7088003 | 12 | 200512 | 0 |